Although amyloid plaques and tau tangles are thought to be central to AD, over 2000 clinical trials targeting plaques, tangles, neurotransmitters, and other related mechanisms have failed to successfully treat AD [45]. This evidence concerns the gene MAPT and Alzheimer disease.